Dr. Koster is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Rheumatology, 2013 - 2016
Loyola University Medical CenterResidency, Internal Medicine, 2009 - 2013
Loyola University Chicago Stritch School of MedicineClass of 2009
Certifications & Licensure
MN State Medical License 2013 - 2025
IL State Medical License 2009 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- 6 citationsLow-dose vemurafenib monotherapy in BRAFV600E-mutated Erdheim-Chester diseaseGordon Ruan, Antonious Z. Hazim, Jithma P. Abeykoon, Caleb Scheckel, Robert Vassallo
Leukemia & Lymphoma. 2020-07-01 - 57 citationsClinical Heterogeneity of the VEXAS Syndrome: A Case Series.Matthew J. Koster, Taxiarchis Kourelis, Kaaren K. Reichard, Tanaz A. Kermani, David B. Beck
Mayo Clinic Proceedings. 2021-10-01 - 21 citationsVEXAS within the spectrum of rheumatologic disease.Matthew J. Koster, Kenneth J. Warrington
Seminars in Hematology. 2021-10-01
Press Mentions
VEXAS Syndrome More Dangerous Than Thought – US Data AnalysisFebruary 7th, 2023- Study Predicts Higher Prevalence of VEXAS Syndrome (Updated)January 26th, 2023
- VEXAS Syndrome May Be More Common Than Previously KnownJanuary 25th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
